Sunesis

Closed

Sunesis is a biotech company in South San Francisco, United States, founded in 1998. It has raised $85.2M across 2 rounds, most recently a $60.0M Series B in July 2000.

Advancing novel oncology therapeutics

Employees
11–50
Founded
1998
Business Model
B2B
Total Funding
$85.2M
Last Round
$60.0M Series BJul 2000
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, focused on developing and commercializing novel oncology therapeutics. Founded in 1998 and incorporated in Delaware, the company applies its expertise in small-molecule drug discovery to advance treatments for hematologic and solid tumor malignancies. Its lead program, voreloxin, is a first-in-class anticancer quinolone derivative that intercalates DNA and inhibits topoisomerase II. Sunesis has built deep capabilities across all phases of oncology drug development, from preclinical research through Phase III clinical trials, partnering with leading academic and medical research institutions.

Summary

It lists 11–50 employees. It has raised $85.2M in total across 2 rounds, most recently a $60.0M Series B round in Jul 2000. Investors include Credit Suisse First Boston and Warburg Pincus.

Funding & Exit History

Data from Indexed.vcUpdated
MergerMerger with Viracta TherapeuticsFeb 2021

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sunesis on Indexed.vc
<a href="https://indexed.vc/companies/sunesis"><img src="https://indexed.vc/api/badge/company/sunesis" alt="Sunesis on Indexed.vc" width="260" height="76" /></a>